Evidence map›Paper›PMID 41624742›Full record

ArticleIranian journal of pathology2026

Right Atrium Large Masses Due to Endocarditis Following Permcath Insertion After Covid-19-Induced Renal Failure.

Seyed Mohsen Mirhosseini, Hossein Yarmohammadi, Arash Anisian, Fatemeh Ravand, Mahdi Rezaei, Masood Soltanipu

Abstract readCase Reports
In one paragraph

Article in Iranian journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Seyed Mohsen MirhosseiniCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hossein YarmohammadiCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Arash AnisianGeneral Practitioner (GP), Ebne-sina Medical Center (EMC), Tehran, Iran.
Fatemeh RavandMedical Students Research Committee, Shahed University, Tehran, Iran.
Mahdi RezaeiCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Masood SoltanipuCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Objective: COVID-19 infection is known to affect the kidneys, potentially resulting in Acute Kidney Injury (AKI). In some patients, however, renal failure may necessitate hemodialysis following a COVID-19 infection. Pneumothorax, hemothorax, cardiac arrhythmias, and endocarditis are some complications associated with Permcath insertion, a type of vascular access used in hemodialysis. Case Presentation: In this report, we present a 29-year-old man who suffered from endocarditis following hemodialysis treatments through a Permcath because of acute renal failure following COVID-19. Removing the large masses (3×3 cm) inside the right atrium (RA) and taking out the Permcath was completed surgically. Conclusion: A suitable Permcath and its accurate insertion are recommended to provide prompt AKI treatment and prevent further complications, such as endocarditis and thrombosis.

Indexed as

Acute renal failureCOVID-19EndocarditisHemodialysisPermcath

Identifiers

PMID41624742
PMCPMC12860238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.